Daniel Galles
SlowingNamed in filings at Allumia VenturesOn the current fund
- Board seats filed
- 9
Named in filings at Allumia VenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Wildflower Health | Digital health | November 2024 | Hatteras Venture Partners |
| Xealth | Not yet classified | February 2024 | None on file |
| Kyruus | Digital health | September 2022 | Lux Capital |
| RxRevu | Not yet classified | June 2021 | None on file |
| Clearsense | Not yet classified | November 2018 | None on file |
| Gauss Surgical | Digital health | March 2016 | Sonder Futures |
| Aventura HQ | Digital health | January 2015 | HLM Venture Partners |
| Spinal Kinetics | Healthcare services | May 2014 | SV Life Sciences |
| Transcend Medical | Not yet classified | March 2014 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Daniel Galles on the board, based on 5 filed seats with a verified or cited source.
4 more filed seats not yet classified, left out of the shares above.